Phillip Blaskovich

USPTO Granted Patents = 30 (Patent Applications = 7)

CIPO Patents = 10 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 208(Granted Patents)

Company Filing History:

Confluent Surgical, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11872244 - Thixotropic oxidized cellulose solutions and medical applications thereof (2024-01-16),

2. 11065204 - Oxidized cellulose microspheres (2021-07-20),

3. 11053323 - Dissolution of oxidized cellulose and particle preparation by cross-linking with multivalent cations (2021-07-06),

4. 10982012 - Dissolution of oxidized cellulose (2021-04-20),

5. 10584184 - Medical devices based on oxidized cellulose (2020-03-10),

6. 10561744 - Multi-encapsulated formulations made with oxidized cellulose (2020-02-18),

7. 10449152 - Drug loaded microspheres for post-operative chronic pain (2019-10-22),

8. 10426730 - Oxidized cellulose microspheres (2019-10-01),

9. 10413566 - Thixotropic oxidized cellulose solutions and medical applications thereof (2019-09-17),

10. 10328095 - Resorbable oxidized cellulose embolization microspheres (2019-06-25),

11. 10188608 - Oxidized cellulose microspheres (2019-01-29),

12. 10040871 - Medical devices based on oxidized cellulose (2018-08-07),

13. 9919063 - Multi-encapsulated formulations made with oxidized cellulose (2018-03-20),

14. 9814844 - Drug-delivery cannula assembly (2017-11-14),

15. 9782430 - Resorbable oxidized cellulose embolization solution (2017-10-10),

Introduction

Phillip Blaskovich, a resident of Salem, Massachusetts, is a prominent inventor recognized for his significant contributions to the field of medical innovations. With an impressive portfolio of 30 patents, he has made notable strides in the development of cutting-edge treatments and medical applications.

Latest Patents

Among his latest patents, Blaskovich has introduced methods and processes that enhance medical treatments. One such patent is titled "Thixotropic Oxidized Cellulose Solutions and Medical Applications Thereof." This innovative method involves agitating a thixotropic oxidized cellulose solution, administering it to a target tissue site, and allowing the solution to gel at that specific location, thus aiding in healing and recovery.

Another noteworthy patent is the "Oxidized Cellulose Microspheres." This process details the formation of microspheres through several innovative steps, including the creation of a modified cellulose solution and the incorporation of bioactive agents to produce an emulsion. This sophisticated approach culminates in the formation of a variety of modified cellulose microspheres that hold potential for various medical applications.

Career Highlights

Blaskovich has lent his expertise to reputable companies in the medical field, including Covidien LP and Confluent Surgical, Inc. His work at these organizations has enabled him to further refine his inventions and push the boundaries of medical treatments.

Collaborations

Collaboration is key in driving innovation. Throughout his career, Blaskovich has teamed up with skilled professionals such as Rachit Ohri and Joshua Kennedy. Their collective expertise has led to advancements in technologies that address critical medical needs.

Conclusion

Phillip Blaskovich continues to be a trailblazer in the realm of medical innovations. With his extensive patent portfolio and dedication to advancing medical technology, he is well-positioned to make lasting impacts on patient care and treatment methodologies in the years to come. His work not only highlights the importance of innovative solutions in healthcare but also inspires future inventors to pursue their ideas passionately.

This text is generated by artificial intelligence and may not be accurate.